H. Abdel-Aty - Div Radiotherapy & Imaging, Inst Canc Res

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Quantitative Impact of Prostate-Specific Membrane Antigen (PSMA) PET/CT Staging in Newly Diagnosed Metastatic Prostate Cancer and Treatment-Decision Implications

Hoda Abdel-Aty,Nabil Hujairi, Iain Murray, Yathushan Yogeswaran,Nicholas van As,Nicholas James

BJR OPENno. 1 (2024)

引用0浏览0WOS引用

2969: Assessing Auto-Contours: Inter- and Intra-Rater Reliability with a Novel Qualitative Scoring System

Katherine Mackay, David Bernstein,Sooha Kim,Harshani Green,Binnaz Yasar, Ragu Ratnakumaran,Hoda Abdel-Aty,Charleen Chan Wah Hak,Vincent Khoo,Alexandra Taylor

RADIOTHERAPY AND ONCOLOGY (2024): S2980-S2983

引用0浏览0引用

1658Tip the STAMPEDE2 177Lutetium-Psma-617 (177Lu-Psma-617) Trial: A Phase III, Randomised, Open-Label Trial in Patients with Metastatic Prostate Cancer (mpc) Starting Androgen Deprivation Therapy (ADT)

M. Padden-Modi,H. Abdel-Aty, C. Jones,L.C. Brown, P. Dutey-Magni, Y. Yogeswaran, A. Horsey,C.L. Amos, I. Murray, N. Hujairi,N. Tunariu,R. Millman,W. Cross, V. Kasivisvanathan,M.K. Parmar,N. Clarke,S. Gillessen,G. Attard,C. Parker,N.D. James

Annals of Oncology (2024): S999-S1000

引用0浏览0引用

How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial

Minal Padden-Modi,Hannah Rush,Hoda Abdel-Aty,David Matheson,Robin Millman, Patrick Williams,Bertrand Tombal,Nicholas James

European Urology Oncology（2024）

引用0浏览0WOS引用

2845: Patterns of PSMA PET/CT-detected Nodal Metastases in Relation to the Dominant Intraprostatic Lesion

Hoda Abdel-Aty,Nora Sundahl,Nabil Hujairi,Daniel Levine,Sue Chua,Alison Tree, Christopher Parker,Yae-eun Suh,Nicholas van As,Rosalind Eeles,Vincent Khoo,Robert Huddart,Declan Cahill,Nicholas James,Julia Murray

RADIOTHERAPY AND ONCOLOGY (2024): S2576-S2578

引用0浏览0引用

1657Tip the STAMPEDE2 Stereotactic Ablative Body Radiotherapy (SABR) Trial: A Phase III, Randomised, Open-Label Trial in Patients with Newly Diagnosed Oligometastatic Prostate Cancer (PC) Starting Androgen Deprivation Therapy (ADT)

H. Abdel-Aty,C.L. Amos,L.C. Brown, Y. Yogeswaran, P. Niem, P. Dutey-Magni, V. Kasivisvanathan, R. Bennett,N. Clarke,A. Sachdeva,W. Cross,L. Farrelly,D. Matheson,C. Peedell, P. DIEZ,O. Naismith,M.K. Parmar,G. Attard,N. van As,N.D. James

Annals of Oncology (2024): S999

引用0浏览0引用

1787P Prostate Specific Membrane Antigen Positron Emission Tomography (PSMA PET)-directed Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer (mhspc): Implications for the STAMPEDE2 Trial Design

H. Abdel-Aty, N. Hujairi, I. Murray, Y. Yogeswaran,L.R. Murphy,N. van As,L.C. Brown,N.D. James

Annals of Oncology（2023）

引用0浏览0引用

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer

H. Abdel-Aty, L. O'Shea,C. Amos,L. C. Brown,E. Grist,G. Attard,N. Clarke,W. Cross,C. Parker,M. Parmar, N. Vas As,N. James

Clinical Oncologyno. 10 (2023): e628-e635

引用2浏览0WOS引用

Prostate Specific Membrane Antigen Positron Emission Tomography (PSMA PET)-directed Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer (mhspc): Implications for the STAMPEDE2 Trial Design

H. Abdel-Aty, N. Hujairi, I. Murray, Y. Yogeswaran,L. R. Murphy,N. Van As,L. C. Brown,N. D. James

ANNALS OF ONCOLOGY (2023): S966-S966

引用0浏览0引用

Abiraterone Acetate Plus Prednisolone with or Without Enzalutamide for Patients with Metastatic Prostate Cancer Starting Androgen Deprivation Therapy: Final Results from Two Randomised Phase 3 Trials of the STAMPEDE Platform Protocol

LANCET ONCOLOGY（2023）

引用29浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn